Inventor
TANG PENG CHO
CN126 patents
⚠️ This page may combine multiple inventors who share the name “TANG PENG CHO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SUGEN INC
45 patentsUS6133305AOct 17, 2000
3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity
SUGEN INC125 citations99
US5886020AMar 23, 1999
3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
SUGEN INC376 citations99
US5883116AMar 16, 1999
3-(2'-alkoxybenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
SUGEN INC180 citations99
US5883113AMar 16, 1999
3-(4'-Bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease
SUGEN INC373 citations99
US5880141AMar 9, 1999
Benzylidene-Z-indoline compounds for the treatment of disease
SUGEN INC106 citations99
US5834504ANov 10, 1998
3-(2'-halobenzylidenyl)-2-indolinone compounds for the treatment of disease
SUGEN INC358 citations99
US5792783AAug 11, 1998
3-heteroaryl-2-indolinone compounds for the treatment of disease
SUGEN INC589 citations99
US5650415AJul 22, 1997
Quinoline compounds
SUGEN INC235 citations99
US6573293B2Jun 3, 2003
Pyrrole substituted 2-indolinone protein kinase inhibitors
SUGEN INC174 citations98
US6506763B2Jan 14, 2003
3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity
SUGEN INC76 citations98
US6395734B1May 28, 2002
Pyrrole substituted 2-indolinone protein kinase inhibitors
SUGEN INC79 citations98
US5792771AAug 11, 1998
Quinazoline compounds and compositions thereof for the treatment of disease
SUGEN INC155 citations98
US5789427AAug 4, 1998
Methods and compositions for inhibiting cell proliferative disorders
SUGEN INC264 citations98
US5773459AJun 30, 1998
Urea- and thiourea-type compounds
SUGEN INC117 citations98
US5773476AJun 30, 1998
Methods and compositions for inhibiting cell proliferative disorders
SUGEN INC153 citations98
US5763441AJun 9, 1998
Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
SUGEN INC111 citations97
US6696448B2Feb 24, 2004
3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors
SUGEN INC65 citations96
US6683082B2Jan 27, 2004
Bicyclic protein kinase inhibitors
SUGEN INC60 citations96
US6677368B2Jan 13, 2004
4-aryl substituted indolinones
SUGEN INC72 citations96
US6653308B2Nov 25, 2003
3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
SUGEN INC75 citations96
US6610688B2Aug 26, 2003
4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
SUGEN INC74 citations96
US6486185B1Nov 26, 2002
3-heteroarylidene-2-indolinone protein kinase inhibitors
SUGEN INC64 citations96
US6316635B1Nov 13, 2001
2-indolinone derivatives as modulators of protein kinase activity
SUGEN INC87 citations96
US6239161B1May 29, 2001
Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions
SUGEN INC54 citations96
US6225346B1May 1, 2001
Tyrphostin like compounds
SUGEN INC61 citations96
US6143765ANov 7, 2000
Pharmaceutical compositions and methods for modulating signal transduction
SUGEN INC44 citations96
US6103728AAug 15, 2000
Quinazolines
SUGEN INC58 citations96
US5935993AAug 10, 1999
Tyrphostin like compounds
SUGEN INC72 citations96
US5891917AApr 6, 1999
Certain acrylonitrile-sulfonamide derivatives
SUGEN INC75 citations96
US5763470AJun 9, 1998
Benzopyran compounds and methods for their use
SUGEN INC57 citations96
US7125905B2Oct 24, 2006
Pyrrole substituted 2-indolinone protein kinase inhibitors
SUGEN INC59 citations95
US6777417B2Aug 17, 2004
3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene-2-indolinone derivatives as kinase inhibitors
SUGEN INC56 citations95
US7119090B2Oct 10, 2006
Pyrrole substituted 2-indolinone protein kinase inhibitors
SUGEN INC18 citations93
US6849641B1Feb 1, 2005
Azaindole tyrosine kinase inhibitors
SUGEN INC38 citations93
US6514981B1Feb 4, 2003
Methods of modulating tyrosine protein kinase function with indolinone compounds
SUGEN INC30 citations93
US6329375B1Dec 11, 2001
Tricyclic quinoxaline derivatives as protein tyrosine kinase inhibitors
SUGEN INC27 citations93
US6316429B1Nov 13, 2001
Bicyclic protein kinase inhibitors
SUGEN INC19 citations93
US6225335B1May 1, 2001
3-(4′-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease
SUGEN INC21 citations93
US6051593AApr 18, 2000
3-(cycloalkanoheteroarylidenyl)-2- indolinone protein tyrosine kinase inhibitors
SUGEN INC17 citations93
US6004967ADec 21, 1999
Psoriasis treatment with quinazoline compounds
SUGEN INC74 citations93
US5883110AMar 16, 1999
Pharmaceutical compositions and methods for modulating signal transduction
SUGEN INC31 citations93
US5760066AJun 2, 1998
Compounds and methods for inhibiting hyper-proliferative cell growth
SUGEN INC30 citations93
US5721277AFeb 24, 1998
Compounds and methods for inhibiting hyper-proliferative cell growth
SUGEN INC27 citations93
US7572924B2Aug 11, 2009
Pyrrole substituted 2-indolinone protein kinase inhibitors
SUGEN INC25 citations92
US6710067B2Mar 23, 2004
Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
SUGEN INC20 citations92
YISSUM RES DEV CO
2 patentsGLYCOMED INC
2 patentsUNIV CALIFORNIA
1 patentShowing the top 50 of 126 patents by PatentIndex Score.